Table 4 Summary results from post hoc mixed-model analysis of primary and secondary outcomes, with baseline measurement (i.e. age, gender, HADS) included as covariate
Primary and secondary outcomes | Visit | Difference in least squares mean for intervention vs treatment as usual (95% CI) | P value |
|---|---|---|---|
HADS Anxiety | Pre-treatment | Â | Â |
Post-treatment | − 2.67 (− 4.32 to − 1.03) | 0.002 | |
Follow-up | − 1.84 (− 3.56 to − 0.13) | 0.04 | |
HADS Depression | Pre-treatment | Â | Â |
Post-treatment | − 1.98 (− 3.41 to − 0.55) | 0.007 | |
Follow-up | − 1.43 (− 2.92 to 0.07) | 0.06 | |
HADS | Pre-treatment | Â | Â |
Post-treatment | − 4.65 (− 7.27 to − 2.03) | 0.0006 | |
Follow-up | − 3.20 (− 5.92 to − 0.48) | 0.02 | |
WHO DAS | Pre-treatment | Â | Â |
Post-treatment | − 3.81 (− 6.59 to − 1.04) | 0.008 | |
Follow-up | − 4.44 (− 7.34 to − 1.55) | 0.003 | |
PCL | Pre-treatment | Â | Â |
Post-treatment | − 3.30 (− 8.71 to 2.12) | 0.23 | |
Follow-up | − 5.17 (− 11.08 to − 0.33) | 0.04 | |
PHQ | Pre-treatment | Â | Â |
Post-treatment | − 2.51 (− 4.96 to − 0.06) | 0.04 | |
Follow-up | − 3.04 (− 5.32 to − 0.76) | 0.01 | |
Days of these difficulties present | Pre-treatment | Â | Â |
Post-treatment | − 4.33 (− 7.90 to − 0.77) | 0.02 | |
Follow-up | − 2.84 (− 6.47 to 0.79) | 0.12 | |
Days of total disability | Pre-treatment | Â | Â |
Post-treatment | − 2.51 (− 5.18 to 0.15) | 0.06 | |
Follow-up | − 1.69 (− 4.41 to 1.02) | 0.22 | |
Days of activity reduce | Pre-treatment | Â | Â |
Post-treatment | − 3.15 (− 6.41 to 0.10) | 0.06 | |
Follow-up | − 1.95 (− 5.27 to 1.37) | 0.25 | |
Perceived social support | Pre-treatment | Â | Â |
Post-treatment | 4.45 (− 1.05 to 9.95) | 0.11 | |
Follow-up | 2.52 (− 3.22 to 8.27) | 0.39 | |
PSYCHLOPS | Pre-treatment | Â | Â |
Post-treatment | − 2.58 (− 4.39 to − 0.77) | 0.006 | |
Follow-up | − 1.66 (− 3.54 to 0.23) | 0.08 |